Responder Analysis Evaluating the Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) in Patients With Moderate to Severe Asthma With Versus Without Fixed Airflow Obstruction (FAO)

被引：0

|

作者：

Tashkin, D. P.

Chipps, B. E.

Uryniak, T.

Trudo, F.

机构：

来源：

ALLERGY AND ASTHMA PROCEEDINGS | 2014年 / 35卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：85 / 86

页数：2

相关论文

共 50 条

[31] Tolerability of budesonide (BUD)/Formoterol (FM) pressurized metered-dose inhaler (pMDI): Pooled adverse event (AE) data from clinical studies of children, adolescents, and adults with asthma
Rosenwasser, L. J.
Peters, S. P.
Vervaet, P.
O'Brien, C. D.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S154 - S154
[32] Differential Long-Term Pulmonary Function Outcomes Of Budesonide/Formoterol Pressurized Metered-Dose Inhaler PMDI And Budesonide PMDI In African-American Patients With Asthma
Brown, R. W.
Uryniak, T.
Lampl, K. L.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
[33] Effect of budesonide and formoterol administered via one pressurized metered-dose inhaler on lung function in adults and adolescents with moderate to severe persistent asthma
Noonan, M. J.
Rosenwasser, L. J.
Martin, P.
O'Brien, C. D.
O'Dowd, L.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S2 - S2
[34] Pharmacokinetics of Budesonide and Formoterol Administered Via 1 Pressurized Metered-Dose Inhaler in Patients With Asthma and COPD
Tronde, Ann
Gillen, Michael
Borgstrom, Lars
Lotvall, Jan
Ankerst, Jaro
JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (11): : 1300 - 1308
[35] BRONCHODILATOR REVERSIBILITY AND ONSET WITH BUDESONID/FORMOTEROL PRESSURIZED METERED-DOSE INHALER (BUD/FM PMDI) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Celli, B. R.
Tashkin, D. P.
Rennard, S. I.
McElhattan, J.
Martin, U. J.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A61 - A61
[36] Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) Versus Budesonide Dry Powder Inhaler (DPI) on Predose FEF25-75% over 26 Weeks in Children with Asthma
Berger, W. E.
Geller, D. E.
O'Brien, C. D.
Uryniak, T.
Lampl, K.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[37] Predose Forced Expiratory Flow Between 25% and 75% (FEF25-75%) in Inhaled Corticosteroid (ICS)-Dependent Patients With Mild to Moderate or Moderate to Severe Persistent Asthma Receiving Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI)
Pearlman, D. S.
Uryniak, T.
O'Brien, C. D.
Martin, U. J.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S158 - S158
[38] Asthma control with once-daily (qd) Budesonide/Formoterol pressurized metered-dose inhaler (pMDI) in adults and adolescents with asthma previously stable with twice-daily (bid) Budesonide/Formoterol pMDI
Oppenheimer, J. J.
Kerwin, E. M.
LaForce, C.
Miller, C. J.
O'Dowd, L.
Goldman, M.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S8 - S8
[39] Effect of Fixed Airflow Obstruction (FAO) Status on Lung Function, Asthma Control Days (ACD), and Asthma Symptom Score (AS) Responses to Budesonide/Formoterol (BUD/FM) Treatment in Patients with Moderate-to-Severe Asthma
Tashkin, Donald P.
Trudo, Frank
DePietro, Michael
Chipps, Bradley E.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB5 - AB5
[40] SAFETY OF BUDESONIDE/FORMOTEROL PRESSURIZED METERED-DOSE INHALER VERSUS BUDESONIDE IN CHILDREN (6-<12 YEARS) WITH ASTHMA
Lanz, M.
Eckerwall, G.
McLaren, J.
Lamarca, R.
Puu, M.
Jorup, C.
Sandin, K.
Pearlman, D.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S62 - S62

← 1 2 3 4 5 →